BGI Genomics Co., Ltd.
SZSE:300676.SZ
46.6 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,866.921 | 4,349.637 | 7,046.132 | 6,766.137 | 8,397.23 | 2,800.412 | 2,536.406 | 2,095.544 | 1,711.498 | 1,318.704 | 1,131.982 | 1,047.381 | 794.839 |
| Cost of Revenue
| 2,263.225 | 2,179.031 | 3,357.101 | 2,835.423 | 3,353.046 | 1,300.545 | 1,132.558 | 902.204 | 711.249 | 586.203 | 612.138 | 463.341 | 415.359 |
| Gross Profit
| 1,603.696 | 2,170.607 | 3,689.031 | 3,930.715 | 5,044.184 | 1,499.867 | 1,403.848 | 1,193.34 | 1,000.25 | 732.5 | 519.844 | 584.039 | 379.481 |
| Gross Profit Ratio
| 0.415 | 0.499 | 0.524 | 0.581 | 0.601 | 0.536 | 0.553 | 0.569 | 0.584 | 0.555 | 0.459 | 0.558 | 0.477 |
| Reseach & Development Expenses
| 606.175 | 528.925 | 535.786 | 487.148 | 619.642 | 317.315 | 260.92 | 174.314 | 176.724 | 101.764 | 130.636 | 50.595 | 39.915 |
| General & Administrative Expenses
| 129.617 | 128.58 | 140.85 | 156.787 | 126.248 | 72.59 | 55.658 | 50.216 | 68.811 | 43.375 | 37.674 | 137.948 | 106.074 |
| Selling & Marketing Expenses
| 567.321 | 549.686 | 1,608.668 | 1,238.311 | 1,078.444 | 618.737 | 514.276 | 401.861 | 327.612 | 240.551 | 213.92 | 220.852 | 136.124 |
| SG&A
| 696.937 | 1,507.212 | 1,749.518 | 1,395.098 | 1,204.692 | 691.327 | 569.934 | 452.077 | 396.423 | 283.927 | 251.594 | 358.8 | 242.198 |
| Other Expenses
| 1,175.352 | -13.588 | 151.731 | 200.85 | 406.671 | 87.512 | -3.501 | -7.374 | 29.014 | 25.965 | 22.191 | 6.006 | 1.92 |
| Operating Expenses
| 2,478.464 | 2,019.958 | 2,437.035 | 2,083.096 | 2,231.006 | 1,096.154 | 911.004 | 708.494 | 673.087 | 467.182 | 457.46 | 365.387 | 253.858 |
| Operating Income
| -874.768 | 150.649 | 1,659.187 | 1,822.835 | 2,498.174 | 330.129 | 478.416 | 503.508 | 382.343 | 303.908 | 53.56 | 199.022 | 104.382 |
| Operating Income Ratio
| -0.226 | 0.035 | 0.235 | 0.269 | 0.297 | 0.118 | 0.189 | 0.24 | 0.223 | 0.23 | 0.047 | 0.19 | 0.131 |
| Total Other Income Expenses Net
| -11.347 | -35.114 | -379.029 | -188.626 | -55.88 | -1.943 | -3.501 | -8.002 | 28.967 | 20.282 | 21.417 | -13.991 | -19.401 |
| Income Before Tax
| -886.115 | 115.536 | 1,006.957 | 1,745.893 | 2,442.294 | 328.185 | 474.916 | 496.133 | 409.687 | 324.19 | 74.909 | 204.661 | 106.221 |
| Income Before Tax Ratio
| -0.229 | 0.027 | 0.143 | 0.258 | 0.291 | 0.117 | 0.187 | 0.237 | 0.239 | 0.246 | 0.066 | 0.195 | 0.134 |
| Income Tax Expense
| 25.986 | 21.854 | 197.515 | 268.195 | 340.242 | 49.666 | 67.072 | 72.447 | 59.67 | 52.135 | 16.38 | 31.993 | 20.867 |
| Net Income
| -902.691 | 92.9 | 802.765 | 1,461.536 | 2,090.285 | 276.334 | 386.646 | 398.092 | 332.691 | 262.1 | 28.121 | 135.881 | 81.734 |
| Net Income Ratio
| -0.233 | 0.021 | 0.114 | 0.216 | 0.249 | 0.099 | 0.152 | 0.19 | 0.194 | 0.199 | 0.025 | 0.13 | 0.103 |
| EPS
| -2.19 | 0.23 | 1.96 | 3.56 | 5.25 | 0.69 | 0.97 | 1.05 | 0.92 | 0.77 | 0.11 | 1.66 | 1.32 |
| EPS Diluted
| -2.19 | 0.23 | 1.96 | 3.55 | 5.24 | 0.69 | 0.97 | 1.05 | 0.92 | 0.77 | 0.11 | 1.66 | 1.32 |
| EBITDA
| -350.567 | 643.932 | 1,560.622 | 2,139.474 | 2,762.508 | 600.68 | 671.97 | 636.584 | 527.551 | 432.78 | 180.469 | 259.657 | 145.124 |
| EBITDA Ratio
| -0.091 | 0.148 | 0.221 | 0.316 | 0.329 | 0.214 | 0.265 | 0.304 | 0.308 | 0.328 | 0.159 | 0.248 | 0.183 |